IntermediaterespiratoryPhysiology
Asthma Mechanism: Airway Inflammation and Reversible Bronchoconstriction
Overview
Asthma is chronic inflammation of the airways punctuated by episodes of reversible narrowing — the wheeze, breathlessness, and chest tightness that define attacks. This mechanism follows the full sequence: IgE sensitization of mast cells, mediator-driven bronchoconstriction within minutes, the eosinophilic late-phase response hours later, and the long-term remodeling that can make obstruction partly permanent. Understanding why asthmatic obstruction reverses — and when it stops reversing — is the key to the whole disease.
Learning objectives
- Describe the IgE–mast-cell pathway that initiates allergic asthma attacks
- Distinguish the early-phase bronchospastic response from the late-phase inflammatory response
- Explain how Poiseuille's law magnifies the effect of airway narrowing
- Define airway remodeling and its effect on reversibility
- Interpret the spirometric pattern of reversible airflow limitation
Process steps
In susceptible airways, inhaled proteins such as pollen, dust-mite, or animal dander are captured by dendritic cells and presented to T-helper-2 lymphocytes. Th2 cytokines (IL-4, IL-13) drive B cells to produce IgE antibodies, which arm mast cells and basophils by binding their surface receptors. The airway is now sensitized — primed to overreact — though no symptoms have occurred yet.
On re-exposure, the allergen binds adjacent IgE molecules on mast cells, cross-linking their receptors. Non-allergic triggers — exercise, cold dry air, viral infections, smoke, strong emotions — can provoke attacks through related pathways involving airway nerves, osmolarity shifts, and epithelial injury. The result converges on the same endpoint: sudden mediator release in the airway wall.
Degranulating mast cells dump histamine, tryptase, prostaglandin D2, and leukotrienes C4, D4, and E4 into the airway wall. These mediators contract bronchial smooth muscle, dilate mucosal blood vessels, increase capillary permeability, and stimulate mucus glands. Leukotrienes are especially potent — roughly a thousand times more bronchoconstricting than histamine — which is why they dominate the sustained response.
Within minutes, contracted smooth muscle narrows the airway lumen, and because resistance rises with the fourth power of radius (Poiseuille's law), even modest narrowing dramatically raises the work of breathing. Mucosal edema and mucus add further obstruction. The patient wheezes — air whistling through narrowed tubes — and spirometry shows a sharp fall in FEV1. This phase typically peaks within 30 minutes and then eases.
Four to eight hours later, recruited eosinophils, basophils, and Th2 lymphocytes infiltrate the airway wall, releasing toxic granule proteins (major basic protein, eosinophil cationic protein) that damage epithelium. Edema, mucus hypersecretion, and cellular infiltration re-narrow the airways for hours to days. This late phase explains why a single exposure can cause symptoms long after the trigger is gone, and why inflammation — not just spasm — defines asthma.
Repeated cycles of injury and repair thicken the airway wall permanently: subepithelial collagen deposition (fibrosis), smooth-muscle hypertrophy and hyperplasia, goblet-cell hyperplasia with mucus-gland enlargement, and new blood vessel formation. Remodeling narrows the baseline caliber and makes hyperresponsiveness partly fixed — the reason long-standing severe asthma loses some of its classic reversibility.
Unlike COPD, asthmatic obstruction largely reverses — spontaneously, with trigger removal, or as inflammation settles. Smooth muscle relaxes, edema drains, and mucus clears, restoring airflow toward normal between episodes. Demonstrating significant reversibility on spirometry (typically a ≥12% and 200 mL rise in FEV1) is the physiologic signature that separates asthma from fixed obstructive disease.
Key variables
| Variable | Unit | Typical range | Role |
|---|---|---|---|
| FEV1/FVC ratio | ratio | ≥0.75–0.80 in healthy adults | The fraction of vital capacity exhaled in the first second. It falls during asthmatic obstruction because narrowed airways slow expiratory flow; its rise back toward normal after an episode demonstrates the reversibility that defines asthma. |
| Peak expiratory flow | L/min | varies; tracked against personal best | The maximum flow achieved during a forced exhalation, dominated by large-airway caliber. Morning dips and wide day-to-day variability reflect unstable airway tone and are used to monitor asthma control over time. |
| Airway resistance | cmH2O/L/s | rises sharply during attacks | Opposition to airflow, governed by Poiseuille's law: resistance is inversely proportional to radius to the fourth power. This fourth-power relationship explains why small amounts of smooth-muscle contraction or edema cause large increases in breathing work. |
| Arterial PCO2 | mmHg | 35–45 normal | Usually low in mild attacks from hyperventilation, but a rising or 'normalizing' PCO2 during a severe attack signals respiratory muscle fatigue and failing ventilation — a physiologic red flag that obstruction has overwhelmed compensation. |
| Airway hyperresponsiveness | provocative dose | exaggerated vs healthy airways | The twitchiness of asthmatic airways — they constrict to stimuli (cold air, exercise, methacholine) that leave normal airways unaffected. It reflects the underlying chronic inflammation and is the trait that persists between attacks. |
Feedback loops
Hypoxic pulmonary vasoconstriction negative feedback
- Bronchoconstriction leaves some alveoli poorly ventilated
- Low alveolar oxygen triggers local arteriolar constriction
- Blood is diverted toward better-ventilated alveoli
- Ventilation–perfusion matching is partially preserved
- Arterial oxygenation is defended despite uneven obstruction
Fatigue spiral in severe attacks positive feedback
- Severe obstruction massively increases the work of breathing
- Respiratory muscles fatigue and ventilation begins to fail
- Arterial CO2 rises and oxygen falls
- Worsening hypoxia and acidosis further weaken muscle function
- Ventilatory failure accelerates
Mucus-plugging cycle positive feedback
- Inflammation drives mucus hypersecretion
- Thick mucus plugs small airways completely
- Trapped air distal to plugs collapses (atelectasis)
- Collapsed regions worsen V/Q mismatch and hypoxia
- Hypoxia and inflammation signaling recruit more inflammatory cells
Asthma is inflammation with reversible narrowing
Asthma is a chronic inflammatory disorder of the airways in which recurrent episodes of wheezing, breathlessness, chest tightness, and cough occur — usually worse at night and early morning. The defining physiologic feature is variable, largely reversible airflow limitation: airways that narrow dramatically during attacks and reopen between them. Underneath every attack lies persistent inflammation, which is why the disease is defined by inflammation first and bronchospasm second.
This page explains body mechanisms for learning purposes. It is not medical advice and does not cover diagnosis or treatment.
The allergic cascade: from sensitization to spasm
The classic allergic pathway runs through IgE: dendritic cells present inhaled allergens to Th2 lymphocytes, B cells make IgE, mast cells arm themselves, and re-exposure triggers explosive mediator release. But asthma has many doors — exercise cools and dries the airways, viruses injure epithelium, and irritants stimulate vagal reflexes. All doors lead to the same room: inflamed, twitchy airways that overreact to the ordinary.
Early phase vs late phase
The early response (minutes) is smooth-muscle contraction driven by histamine and leukotrienes — fast, dramatic, and relatively brief. The late response (4–8 hours) is cellular: eosinophils and lymphocytes infiltrate, epithelium is damaged by granule proteins, and edema plus mucus re-narrow the airways for a day or more. Attacks that seem to resolve and then return are often this biphasic pattern, and it is the late phase that cements asthma as an inflammatory disease.
Early phase = mediators + muscle contraction (minutes). Late phase = inflammatory cells + edema + mucus (hours to days). Treating only the first leaves the second untouched.
Remodeling: when reversible becomes fixed
Years of inflammation remodel the airway wall — collagen beneath the epithelium, more and larger smooth-muscle cells, extra mucus glands, new vessels. These structural changes narrow the resting caliber and blunt reversibility, so severe long-standing asthma can develop a fixed obstructive component resembling COPD. Remodeling is the strongest argument for controlling inflammation early rather than chasing bronchospasm alone.
Reading asthma on spirometry
During obstruction, FEV1 falls more than FVC, so the FEV1/FVC ratio drops. After the episode — or after a bronchodilator — FEV1 rebounds substantially, demonstrating reversibility. Between attacks, spirometry may be entirely normal, which is why a normal test never excludes asthma. Peak-flow diaries showing wide daily variability tell the same story in daily life: unstable, twitchy, reversible airways.
Key points
- Asthma = chronic airway inflammation + variable, reversible airflow limitation
- IgE-armed mast cells release histamine and leukotrienes that constrict smooth muscle
- Early phase (minutes) is bronchospasm; late phase (4–8 h) is eosinophilic inflammation
- Poiseuille's fourth-power law explains why small narrowing causes huge resistance
- Chronic inflammation remodels airways, making some obstruction permanent
- Reversibility on spirometry is the defining physiologic hallmark
Common misconceptions
✓ Truth: Bronchospasm is only the visible half. Chronic eosinophilic inflammation drives hyperresponsiveness, the late-phase response, and long-term remodeling — which is why controlling inflammation, not just relieving spasm, determines the disease course.
✓ Truth: Inflammation and hyperresponsiveness persist between attacks even when breathing feels normal. Silent inflammation is what makes the next trigger dangerous — and what remodeling feeds on over years.
✓ Truth: Any narrowed airway wheezes: COPD, foreign bodies, heart failure, and vocal-cord dysfunction can all produce it. The pattern that points to asthma is variability and reversibility, not the wheeze itself.
Practice questions
Q1. Which mediator is most responsible for the sustained bronchoconstriction of the early asthmatic response?
- Leukotrienes C4, D4, and E4
- Acetylcholine from motor neurons
- Surfactant proteins
- Bicarbonate ions
Mast cells release histamine, prostaglandin D2, and cysteinyl leukotrienes. The leukotrienes are roughly a thousand times more potent bronchoconstrictors than histamine and drive the sustained smooth-muscle contraction of the early phase, while histamine's effect is briefer.
Q2. A patient's FEV1 rises 18% after trigger removal. What does this demonstrate?
- Reversible airflow limitation — the hallmark of asthma
- Fixed obstruction typical of emphysema
- Restrictive lung disease
- Normal airway physiology
Significant reversibility (conventionally ≥12% and 200 mL improvement in FEV1) is the defining physiologic feature of asthma: airways that narrow during attacks and reopen afterward. Fixed obstruction that never reverses points toward COPD or remodeled airways instead.
Q3. Why does modest airway narrowing cause such a large increase in breathing work?
- Airway resistance rises with the inverse fourth power of radius (Poiseuille's law)
- The diaphragm stops working during attacks
- Lung compliance increases dramatically
- Alveoli multiply during bronchospasm
Poiseuille's law states resistance is proportional to 1/r⁴. Halving the airway radius increases resistance sixteen-fold, so even small amounts of smooth-muscle contraction, edema, or mucus impose an enormous increase in the work of breathing.
Q4. What characterizes the late-phase asthmatic response?
- Eosinophilic inflammation, epithelial injury, and mucus hypersecretion 4–8 hours after exposure
- Instantaneous smooth-muscle relaxation
- Permanent alveolar destruction
- Complete resolution of all inflammation
The late phase begins 4–8 hours after exposure as eosinophils, basophils, and lymphocytes infiltrate the airway wall. Their granule proteins damage epithelium while edema and mucus re-narrow airways for hours to days — explaining why symptoms can return long after the trigger is gone.
Click a question to reveal the answer and explanation.
Frequently asked questions
How is asthma different from COPD?
Asthma's airflow limitation is variable and largely reversible — airways narrow during attacks and reopen between them — while COPD's limitation is progressive and mostly fixed from destroyed alveoli and scarred airways. Asthma often starts young with allergic features; COPD follows decades of smoke or dust exposure. Severe long-standing asthma can develop fixed obstruction, blurring the line.
Why are asthma symptoms worse at night?
Airway tone follows a circadian rhythm: cortisol and adrenaline, which naturally relax airways, reach their lowest levels around 4 a.m., while vagal (parasympathetic) bronchoconstricting tone peaks. Cooling of the airways during sleep and lying flat, which pools mucus, add to the effect — the physiologic basis of nocturnal asthma.
What actually happens during an asthma attack?
Trigger exposure causes mast cells to release histamine and leukotrienes, contracting bronchial smooth muscle within minutes. Mucosal swelling and mucus narrow the tubes further, air whistles through as wheeze, and exhaling becomes hard work. Hours later, a second wave of eosinophilic inflammation can re-narrow the airways for a day or more.
Can asthma permanently damage the lungs?
Yes, through remodeling. Repeated inflammation lays collagen beneath the epithelium, enlarges smooth muscle, and multiplies mucus glands, permanently narrowing the airways and reducing reversibility. This structural damage accumulates silently over years, which is why persistent inflammation matters even between noticeable attacks.